首页> 美国卫生研究院文献>Case Reports in Infectious Diseases >Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum
【2h】

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum

机译:伏立康唑有效治疗延长了由apispermum引起的肺移植术后合并椎体盘炎的接受者。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scedosporium/Pseudallescheria species are frequently seen in cystic fibrosis patients. However, disseminated forms after lung transplantation in these patients are rarely seen, but often with poor outcome. In this case report we describe a lung transplant recipient with cystic fibrosis who developed a spondylodiscitis that was caused by Scedosporium apiospermum. The patient was treated with anti-fungal treatment by voriconazole for over three years with a clinical good response and without the need for surgical intervention. To our opinion this is the first anti-fungal treated case of invasive disease caused by Scedosporium/Pseudallescheria in a cystic fibrosis (CF) patient who underwent lung transplantation that survived.
机译:囊孢菌/假单胞菌属物种常出现在囊性纤维化患者中。然而,在这些患者中,肺移植后的散播形式很少见,但结果往往很差。在此病例报告中,我们描述了患有囊性纤维化的肺移植受者,该受者发展了由棉顶孢菌引起的脊椎盘炎。该患者接受伏立康唑抗真菌治疗三年以上,临床反应良好,无需手术干预。在我们看来,这是经肺移植存活的囊性纤维化(CF)患者中由Scedosporium / Pseudallescheria引起的侵袭性疾病的首例抗真菌治疗案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号